“…SSRI treatment, acting via increased synaptic 5-HT concentrations (Goddard et al, 2008), is the first line choice for the treatment of both anxiety (Bandelow et al, 2012;Bandelow et al, 2008) and OCD (Abramowitz et al, 2009;Fineberg, 2004), and has been well studied with the MBT (Table 1). These agents include fluoxetine (Kalariya, Prajapati, Parmar, & Sheth, 2015;Prajapati, Kalaria, Karkare, Parmar, & Sheth, 2011;Uday et al, 2007), fluvoxamine (Harasawa et al, 2006;Matsushima et al, 2009), citalopram (Krass et al, 2010;Li et al, 2006), and paroxetine (Casarotto et al, 2010;Saadat et al, 2006). Furthermore, like the 5-HT releaser fenfluramine (Njung'e & Handley, 1991a),…”